Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX: $APHA.TO) (NYSE: $APHA) (TSXV: $PCLO.V) (CSE: $AUSA.C) (OTC: $AUSCF) (CSE: $THC.C) (OTCQX: $THCBF) (CSE: $LDS.C) (OTCQB: $LDSYF)
Delta, Kelowna, BC - February 6, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX: $APHA.TO) (NYSE: $APHA) (TSXV: $PCLO.V) (CSE: $AUSA.C) (OTC: $AUSCF) (CSE: $THC.C) (OTCQX: $THCBF) (CSE: $LDS.C) (OTCQB: $LDSYF)
Hear Investor ideas cannabis potcast on iTunes
Today's podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com “potcast”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we are looking at announcements from Aphria Inc.(TSX: APHA) (NYSE: APHA), PharmaCielo Ltd. (TSXV:PCLO), Australis Capital Inc. (CSE: AUSA) (OTC: AUSCF), THC BioMed Intl Ltd. (CSE: THC) (OTCQX:THCBF) and Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF).
Aphria Inc. today announced that its Board of Directors has rejected the hostile bid by Green Growth Brands Inc. (CSE:GGB) to acquire all of the outstanding common shares of the Company including any Common Shares that may become issued and outstanding after January 22, 2019, but prior to the expiry of the hostile bid upon the exercise, conversion or exchange of options, warrants, debentures or other securities of the Company exercisable or convertible into Common Shares, other than Common Shares owned by GGB or its affiliates, in exchange for 1.5714 shares of GGB.
Based on the 20-day volume-weighted average price of GGB shares immediately before GGB's announcement of an intention to acquire the Common Shares of the Company, the Hostile Bid reflects a 23% discount to the Company's share price over the same period. The Board made its recommendation after careful consideration and receipt of the recommendation of a committee of its independent directors, who were advised by financial and legal advisors.
PharmaCielo Ltd., the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that its Colombian subsidiary has received approval for the listing of 10 proprietary and unique tetrahydrocannabinol (THC) and cannabidiol (CBD) strains with the national cultivar registry. The Company can now proceed to commercial registration, production and sale of these strains within Colombia as well as for export to global markets.
"Approval of these strains strengthens and confirms PharmaCielo's position as the leading producer in Colombia," said Federico Cock-Correa, President and CEO of PharmaCielo Colombia Holdings S.A.S. "Among those approved is an historic and unique CBD-dominant strain approved for commercial registration and sourced from the Colombian landrace strains held within our fuente semillera,1 the first and only one of its kind registered in Colombia."
Dr. Delon Human, Global Head, Health and Innovation, added that "the commercial value of this 20:1 CBD primary strain is of particular significance with the recent clarification by the World Health Organization (WHO) that medicinal CBD is not regulated under international convention.2 The intensity of the CBD strain profile allows us to efficiently fulfill strong global demand for pure CBD medicinal cannabis oil extracts, which we expect to dramatically increase over the next several years for this strain, as it meets both market and import requirements."
Australis Capital Inc. announced that the Company's common shares have commenced trading on the OTCQB® Venture Market under the ticker symbol "AUSAF". The Company will continue to trade on the Canadian Securities Exchange (the "CSE") under the symbol "AUSA".
"The posting of our shares on the OTCQB, a well-known U.S. securities trading platform, should provide additional liquidity for Australis by allowing U.S. investors to more easily invest in our common stock," said Michael Carlotti, CFO of Australis. "As we continue to aggressively expand our presence within the U.S., the trading of our shares on the OTCQB platform is timely as we anticipate increasing interest in Australis by U.S. investors looking to align with a progressive U.S. growth company."
Australis is also in the process of applying for eligibility for book-entry delivery and depository services of the Depository Trust Company ("DTC"), to facilitate electronic settlement of transfers of its common shares in the United States. DTC eligibility will help enhance the Company's potential investor base and offer a more convenient trading experience for current and future shareholders.
THC BioMed Intl Ltd. announced that it has graduated to the OTCQX Best Market.
"Upgrading to the OTCQX Best Market from the OTCQB Venture Market is important for THC BioMed. This listing is expected to build visibility and provide greater transparency in the United States for THC BioMed," said John Miller, President and CEO.
Today was THC BioMed's first trading day on the OTCQX and the symbol will continue to be "THCBF".
THC BioMed is also pleased to announce that it is in the process of preparing its 1st shipment to the province of Ontario. THC intends to have its products available throughout Canada within the next 6 months.
"We are honoured to have the opportunity to provide our products to Canada's most populous province," said Mr. Miller.
Lifestyle Delivery Systems Inc. announced that its wholly-owned subsidiary, Core Isogenics Inc. has begun nursery operations at the Adelanto facility.
Core Isogenics has begun operations in cannabis plant genetic development. The goal is to control all aspects of plant genetics with consistent and repeatable cannabinoid, terpene and flavonoid profile compositions. The success of this process will result in product consistency that is unmatched in the industry. The plants that will be developed by Core Isogenics will have defined yields and precise genetic profiles for Core Isogenics' cultivation as well as contract growers.
The Core Isogenics nursery will develop its plant genetics technology and produce seeds with identical properties to the formulas required for multiple versions of CannaStrips™, thereby reducing the number of extraction steps currently required to extract ingredients from more than one plant to a single plant extraction with the exact ingredients already in its DNA. The Core Isogenics seeds will be germinated inside of Core Isogenics' climate-controlled, negatively-pressurized, and remotely-monitored rooms to ensure contaminant-free plant development. The seedlings from the nursery will be transported to Core Isogenics' automated cultivation environment which will maximize plant growth and shorten grow cycle.
Lifestyle Delivery Systems Inc.'s CEO, Brad Eckenweiler, stated, "The medicinal future of cannabis depends on the ability of cultivators and manufacturers to deliver the same exacting ingredients consistently. That is only possible if those ingredients can be repeated harvest after harvest, which can be achieved only through the complete control of the cannabis plant genetics. Currently the cannabis market is a menagerie of cross strains constantly splicing and cloning creating weaker and weaker genetics in search of THC, which has resulted in the need for many cultivators to use herbicides, fungicides and pesticides. We believe our approach can change the direction of cannabis cultivation for the better. Fifty years ago this plant grew wild without chemicals or human intervention and we will develop that plant again through our genetic pollination program, without cloning or GMO technology." Mr. Eckenweiler went on to say, "By the way, we just witnessed our first generation of seeds popping into the cannabis world." The Company is confident that the Core Isogenics technology and the resulting isogenic strains will benefit the entire cannabis industry.
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment